Preclinical study of a new (177)Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells

OBJECTIVE(S): Somatostatin receptor-positive neuroendocrine tumors have been targeted using various peptide analogs radiolabeled with therapeutic radionuclides for years. The better biomedical properties of radioantagonists as higher tumor uptake make these radioligands more attractive than agonists...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asia Ocean J Nucl Med Biol
Main Authors: Behnammanesh, Hossein, Erfani, Mostafa, Hajiramezanali, Maliheh, Jokar, Safura, Geramifar, Parham, Sabzevari, Omid, Amini, Mohsen, Mazidi, Seyed Mohammad, Beiki, Davood
Formato: Artigo
Idioma:Inglês
Publicado em: Mashhad University of Medical Sciences 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7354249/
https://ncbi.nlm.nih.gov/pubmed/32714998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/AOJNMB.2020.44432.1299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados